뉴스
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded , with bargain hunting returning to beaten-down growth and biotech names.
- Seeking Survival Strategies in the ‘Era of Self-Reliance’; John Hamre Korea Visit After Steppin... John Hamre Makes Visits Korea After Stepping Down as CSIS Chairman… Seeking Survival Strategies
- '정치에 오염된 월드컵' 백악관 내부 "정부 차원에서 개입하자" (That's when senior Trump administration officials hatched a plan that would go down as one of the most